Yes, there’s a tabletop exercise involving a Nipah virus bioterror attack on July 4. Yes, the virus (pathogen, whatever you want to call it) has been tampered with in a lab. Yes, there’s a vaccine.
But pattern recognition is strictly for conspiracy theorists.
Whatever. I figure that if the threat is amplified enough, they’ll have to regroup in order to keep calling us conspiracy theorists. I’m cool with that.
Having said that, here’s what’s circulating…
You can read the full 2024 National Blueprint for Biodefense here, but here’s the scenario they’re preparing for:
Nine weeks ago, some nation or terrorist group—we still do not know who—attacked the Nation’s Capital and other US cities with biological weapons as we celebrated Independence Day. The infectious agent they used killed at least 280,000 Americans and infected at least 400,000 throughout the country in a single day, in addition to the 200,000 dead and 800,000 sickened animals. These numbers will increase as the disease spreads. Many of our own colleagues and staff here in Congress fell ill and died. Coordinated attacks in allied nations in the days that followed killed tens of thousands more.
We are now hearing that the terrorists conducted smaller scale attacks in American cities and localities prior to the July 4 incidents to test our defenses and gauge our responses. These smaller-scale attacks went largely unnoticed.
Laboratory tests confirm that Nipah virus caused the disease, but we still do not know what methods our adversaries used to infect humans and spread the disease among livestock in rural communities.
Based on what David Martin’s saying, you may want to consider skipping the big fireworks events this year.
They’ve seeded collective consciousness, as usual.
Of course there’s a vaccine. (And it’s already getting fast-tracked by the European Medicines Agency.)
The experimental vaccine is manufactured by Moderna, Inc., Cambridge, Massachusetts, and was developed in collaboration with NIAID’s Vaccine Research Center. It is based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines…
“Nipah virus poses a considerable pandemic threat because it mutates relatively easily, causes disease in a wide range of mammals, can transmit from person-to-person, and kills a large percentage of the people it infects,” said NIAID Director Anthony S. Fauci, M.D. “The need for a preventive Nipah virus vaccine is significant.”
(It mutates really easily in a bioweapons lab…)
As always, it’s helpful to check out exclusion criteria for these vaccine clinical trials. They can’t learn about safety or efficacy in pre-existing conditions they don’t examine. You can check out the list of 25 groups they don’t want to test this vaccine on here.
And before you submit to pandemic fear, it’s important to note that the WHO recognizes that not everyone who get’s infected becomes ill. This always skews the statistics, as it obscures the true number of people who are exposed and therefore the true percentage of people who get sick and/or die. (The same applies for Ebola.)
Here’s what Dr. Mike Yeadon has to say about Nipah:
Unfortunately, we’re not just dealing with nature…
J.D. Vance, who invested in this company, AmplifyBio... his parent company, Battelle Institute... is a DOD-affiliated entity... [and] they were running several studies; one of them was making a chimeric Nipah–Ebola virus."
Retired pharma R&D executive Sasha Latypova (@sasha_latypova) describes on a recently posted Flashlights podcast (@CorneliaMrose) how Vice President J.D. Vance's parent company, Battelle Institute, is a DOD-affiliated entity that was "running several studies," including one "making a chimeric Nipah–Ebola virus."
Latypova goes on to tie the studies run by Battelle to a biopharmaceutical giant dubbed National Resilience Inc. Specifically, the pharma insider notes that National Resilience was one of the collaborators on the study making the chimeric Nipah-Ebola virus. "Importantly, they mentioned Resilience... who manufactured this Nipah–Ebola virus for them, and NIH collaborators who rescued that viral strain." National Resilience is critical because it is an umbrella company of sorts that houses a "humongous number of manufacturing plants... for pharmaceutical companies." Indeed, National Resilience partnered with Moderna to help manufacture its COVID injection. From Grok: "National Resilience partnered with Moderna to manufacture mRNA for Moderna’s COVID-19 vaccine at its facility in Mississauga, Ontario, starting in 2021, for global distribution. This partnership was part of Resilience’s mission to strengthen pharmaceutical supply chains, which was launched in November 2020 with $800 million in funding to address vulnerabilities exposed by the pandemic. "Resilience’s role was as a contract development and manufacturing organization (CDMO), providing expertise in mRNA production, viral vectors, and other biologics to expedite vaccine manufacturing. For example, their Ontario facility, acquired shortly after the company’s founding, was equipped for upstream, downstream, and aseptic fill-finish work, enabling rapid scaling of vaccine production." ---------------Partial transcription of clip---------------- "Let me add about Resilience. It's a very, very important word. [It] stands for a number of things. One of them is apparently there is this National Security Council Resilience Directorate for research, military research, defense research. Okay, so that's, that's one thing. "Another thing. There is a National Resilience, which is a company, it's a private company, ostensibly private company with Scott Gottlieb as one of the board members. It's affiliated with CIA. I wrote several articles about it. Actually. Several people pointed this out. It's they bought up. So this is clearly US government, CIA, defense backed enterprise that purchased a number of formerly pharmaceutical companies, owned biological manufacturing facilities. So they bought them from Pfizer, from Roche, I know from several others. "So now they have this humongous number of manufacturing plants and they call themselves a, contract manufacturing. Contract manufacturing facility for pharmaceutical companies. But they are mentioned in a number of very interesting things. "For example, I also wrote an article about J.D. Vance, who invested in this company, AmplifyBio, which is the contract research organization doing animal studies for pharmaceutical companies. And so his company, parent company Battelle Institute, which is a DOD affiliated entity, they were running several studies. One of them was making a chimeric Nipah–Ebola virus. It's published in Science paper. They're saying we made this chimeric Nipah–Ebola virus. And the collaborators on this project, including AmplifyBio, who provided the animals. "So, importantly, they mentioned Resilience. Resilience, who manufactured this Nipah–Ebola virus for them and NIH collaborators who rescued that viral strain. I don't know where they rescued it from. Probably from Africa. So that's the collaborations that we're talking about. So Resilience, if you start digging and I even wrote an article says all roads lead to Resilience. When you start digging and peeling back the layers, you always arrive at Resilience as a manufacturer of these types of things. And they're backed by CIA, by DOD and obviously they have relationship with this National Security Council Resilience group. I mean it's probably their I mean like their representative. "And also another thing is they use this word resilience colloquially as well. So it's very confusing. But listen for it. Like when you read or listen to their speeches about these things, when you hear resilience, your ears should perk up. They're talking about this."
https://x.com/SenseReceptor/status/1930452570557817330
If you’re curious, here’s where The Science is looking for solutions:
At present, sufficient evidence exists to suggest trialling 1F5, m102.4, and remdesivir (alone or in combination) for prophylaxis and early treatment of Nipah virus disease.
No thanks. After seeing what remdesivir did to Ebola and Covid patients, count me out. You can also find the usual suspects in the funding acknowledgements.
Unsurprisingly, a One Health approach is being explored.
So, just for empowerment’s sake, let’s start collecting ideas for our own solutions…
Home Remedies and Folk Medicine
From a Chinese medicine standpoint, it’s always treat what you observe. We don’t treat Nipah or Ebola, we look a the pattern that’s presenting and treat accordingly. Pre-existing conditions matter (which is why there’s such a spectrum of illness) and will show up in the presentation. Treatments should always reflect that. (I did find a patent application for a Chinese medicine formulation that appears to be a generalized treatment for common presentations of Nipah, but I don’t see any evidence that this is more than theoretical.)
But here are some other suggestions that come up in a cursory search:
This article suggests homeopathic remedies for supportive care, including Arsenicum Album, Gelsemium, Belladonna, Eupatorium Perfoliatum and Rhus Tox. https://homeopathyremedies.org/homeopathic-remedies-for-nipah-virus/
This article offers general health and lifestyle tips (hydration, sleep, nutrition etc). https://dev.medlr.in/blog/7-home-tips-to-recover-from-nipah-virus/
Dr. Vipul Sharma offers some recipes/remedies here: https://www.boloji.com/blogs/1984/nipah-virus-niv-herbal-remedies
•Kwatha (Decoction): Take 5 Tulasi (basil) leaves, 4 Kali Mirch (whole black pepper) beads, 3 Laung (clove) buds and 1 teaspoonful of fresh grated Adraka (ginger). Mix them in a glass of water and boil the entire mixture until the quantity of water is halved. Filter and add a teaspoonful of honey. Your Ayurvedic decoction is ready. Take this decoction twice daily.
•Herbs: Mix ½ to 1 teaspoonful of Sitopaladi Churna with 1 teaspoonful of honey and have it twice daily.
•Golden Milk: Add ¼ teaspoonful of turmeric powder in a glass of warm milk. Drink it every night.
Madhuparni is one of the best herbs to prevent Viral Infection :)
AROGYAM PURE HERBS MADHUPARNI TABLET *
It has been claimed that Madhuparni is one of the greatest herbal remedies for the prevention of swine flu. It is a great immunomodulator. It strengthens the immune system and builds resistance in the body to fight diseases. It may be remembered that swine flu mostly affects the persons having weak immune system. Madhuparni is also a very good remedy to treat fevers especially fevers from unknown reasons.....
Dose : Single Tablet A Day
Dr. Stella Immanuel is also recommending some old standbys…
And it’s always a good idea to keep things flowing…
I can’t vouch for any of these for the treatment of Nipah, but I think they’re worth saving for review.
Based on what I’m seeing in disease descriptions and treatment ideas, we’re looking at preparing for some of the same acute disease patterns that we’ve already seen and the treatment suggestions reflect this. I also think that background environmental toxicity is already priming us for the kind of hyper inflammatory immune responses we’ve seen before. If you’re prone to this, you may already know by now. Hopefully, we all have some useful tools in our gardens, pantries and medicine cabinets.
Meanwhile, let’s hope for an uneventful July 4th weekend!
Additional reading:
You can’t “catch” something that’s never been proven to exist, nor cause disease in anything or anyone, nor that “it” can “spread” between anything or anyone, i.e. is contagious. There’s nothing to fear except what the ruling class plans to do under the guise of a “public health” response to yet another completely fake/wholly manufactured threat and the illusion of a crisis created with fancy computer software, fraudulent tests, fearmongering propaganda, and slick marketing.
About Nipah Virus | Nipah Virus | CDC
https://www.cdc.gov/nipah-virus/about/index.html
"People can be infected with Nipah from:
Direct contact with infected animals, like bats or pigs.
Consuming food or drinks, like fruit or raw date palm sap, that are soiled by infected animals.
Close contact with body fluids of an infected person.
A person may become infected by drinking raw date palm sap or eating fruit that is contaminated by an infected bat. (This initial spread from an animal to a person is known as a spillover event.)
Once a person is infected with Nipah, the virus can spread from person to person.
Caregivers and healthcare providers caring for a patient with Nipah are at a higher risk of becoming infected.
If you travel to or live in an area where Nipah virus outbreaks have occurred, you should:
Wash your hands regularly with soap and water.
Avoid contact with flying fox bats or sick pigs.
Avoid areas where bats roost or
Avoid touching anything that could be soiled by bats.
Avoid eating raw date palm sap or fruit that could be soiled by bats.
Avoid contact with the blood or body fluids of someone with Nipah.
Currently, there are no licensed treatments for Nipah. Treatment is limited to supportive care, including rest, hydration, and treatment of other symptoms."